Brokerages Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) PT at $30.57
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been given an average rating of “Buy” by the eight research firms that are currently covering the firm, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have issued ratings on the […]
11 Oct 16:09 · The Markets Daily